1. Home
  2. JCE vs SCPH Comparison

JCE vs SCPH Comparison

Compare JCE & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JCE
  • SCPH
  • Stock Information
  • Founded
  • JCE 2007
  • SCPH 2013
  • Country
  • JCE United States
  • SCPH United States
  • Employees
  • JCE N/A
  • SCPH N/A
  • Industry
  • JCE Trusts Except Educational Religious and Charitable
  • SCPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • JCE Finance
  • SCPH Health Care
  • Exchange
  • JCE Nasdaq
  • SCPH Nasdaq
  • Market Cap
  • JCE 262.6M
  • SCPH 299.0M
  • IPO Year
  • JCE N/A
  • SCPH 2017
  • Fundamental
  • Price
  • JCE $15.64
  • SCPH $5.62
  • Analyst Decision
  • JCE
  • SCPH Buy
  • Analyst Count
  • JCE 0
  • SCPH 3
  • Target Price
  • JCE N/A
  • SCPH $12.00
  • AVG Volume (30 Days)
  • JCE 49.7K
  • SCPH 2.5M
  • Earning Date
  • JCE 01-01-0001
  • SCPH 11-12-2025
  • Dividend Yield
  • JCE 9.26%
  • SCPH N/A
  • EPS Growth
  • JCE N/A
  • SCPH N/A
  • EPS
  • JCE N/A
  • SCPH N/A
  • Revenue
  • JCE N/A
  • SCPH $49,969,000.00
  • Revenue This Year
  • JCE N/A
  • SCPH $104.30
  • Revenue Next Year
  • JCE N/A
  • SCPH $76.06
  • P/E Ratio
  • JCE N/A
  • SCPH N/A
  • Revenue Growth
  • JCE N/A
  • SCPH 107.79
  • 52 Week Low
  • JCE $11.64
  • SCPH $1.94
  • 52 Week High
  • JCE $14.28
  • SCPH $6.28
  • Technical
  • Relative Strength Index (RSI)
  • JCE 49.72
  • SCPH 63.32
  • Support Level
  • JCE $15.47
  • SCPH $4.33
  • Resistance Level
  • JCE $15.81
  • SCPH $5.62
  • Average True Range (ATR)
  • JCE 0.18
  • SCPH 0.04
  • MACD
  • JCE -0.03
  • SCPH -0.01
  • Stochastic Oscillator
  • JCE 31.13
  • SCPH 80.00

About JCE Nuveen Core Equity Alpha Fund of Beneficial Interest

Nuveen Core Equity Alpha Fund is a diversified closed-end management investment company. Its investment objective is to provide an attractive level of total return, through long-term capital appreciation and through income and gains. The Fund invests in a portfolio of actively managed large-capitalization U.S. common stocks, using the sub-adviser's proprietary quantitative process designed to provide the potential for long-term outperformance. Additionally, the Fund seeks to reduce the volatility of its returns relative to the returns of the Equity Portfolio over extended periods by writing (selling) index call options and/or call options on custom baskets of securities.

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

Share on Social Networks: